Yusuke Hikichi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A cost-effectiveness analysis of deucravacitinib vs. apremilast in moderate-to-severe psoriasis patients in Japan.
Journal: Journal of medical economics
Published: June 05, 2025
A discrete choice experiment on oral and injection treatment preferences among moderate-to-severe psoriasis patients in Japan.
Journal: The Journal of dermatology
Published: August 24, 2022
Treatment patterns, healthcare resource utilization, and costs in patients with moderate-to-severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study.
Journal: The Journal of dermatology
Published: June 03, 2022
Economic evaluation of nivolumab combined with ipilimumab in the first-line treatment of advanced melanoma in Japan.
Journal: Journal of medical economics
Published: October 01, 2020
Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment.
Journal: Patient preference and adherence
Published: August 27, 2019
The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in Japan.
Journal: Journal of medical economics
Published: December 15, 2018
Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting.
Journal: Japanese journal of ophthalmology
Published: August 22, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026